R. Fletcher

R.
John Fletcher is the founder of Fletcher Spaght, Inc., established in 1983, serving as Chief Executive Officer & Managing Partner.
Dr. Fletcher is the founder of Fletcher Spaght Venture Partners LLC, established in 2000, serving as Managing Partner.
Current jobs include Chairman at KORU Medical Systems, Inc. since 2019; Chairman at ClearPoint Neuro, Inc. since 2021; Chairman-Corporate Collaboration Council at Thayer School of Engineering At Dartmouth; Chairman at Vyant Bio, Inc. since 2021; Chairman at Metabolon, Inc. since 2017; Director at Sumitomo Eaton Nova Corp.; and Principal at Catalyst Acquisition Group LLC.
Former jobs include Chairman at OptiNose, Inc. from 2023 to 2025; Director at Spectranetics LLC in 2017; Director at AutoImmune, Inc. from 1991 to 2011; Director at Fischer Imaging Corp.; Director at V.I.
Technologies, Inc. in 2005; Director at NMT Medical, Inc. from 1996 to 2005; Independent Non-Executive Director at Axcelis Technologies, Inc. from 2012 to 2021; Director at Quick Study Radiology, Inc.; Director at GlycoFi, Inc.; Director at Panacos Pharmaceuticals, Inc. from 2005 to 2009; Director at Pilot Software, Inc.; Director at XVionics, Inc.; Director at 4DataLink, Inc.; Director at Adhera Therapeutics, Inc. from 2011 to 2012; Director at LuxCath LLC; Director at Cheetah Medical, Inc. from 2018 to 2019; Director at StemoniX, Inc. from 2020 to 2021; and Senior Manager at The Boston Consulting Group, Inc. Education includes undergraduate studies at George Washington University, graduate studies at Central Michigan University, and an MBA from Southern Illinois University.